Headline: SEC has ordered YNP to amend its financial statements Quarter 3, 2010 and Yearly, 2010 Source: SEC Announcement Details Financial statements commands from the SEC Subject SEC has ordered
Building Confidence in the Capital Market No. 248/2024 SEC instructs NUSA to amend financial statements for the year 2023 and Q3 of 2024 Bangkok, 19 November 2024 – The Securities and Exchange
Re: Disclosure of Information and Practice of Listed Companies Concerning the Acquisition and Disposal of Assets B.E. 2547 dated October 29, 2003 (as amend) (collectively, the “Acquisition and Disposal
supplement, amend, update or revise any such statements. The Company does not make any representation, warranty or prediction that the results anticipated by such forward-looking statements will be achieved
. Segments total may not match to IVL due to holdings segment. Excluding Feedstock price adjustment for captive sales to PET on freight saving. There are no impacts on regional or consolidated EBITDA. Summary
. Segments total may not match to IVL due to holdings segment. Excluding Feedstock price adjustment for captive sales to PET on freight saving. There are no impacts on regional or consolidated EBITDA. Summary
2019. Figure 1: Core EBITDA Evolution Note: Core numbers, total of all regions may not match to IVL due to holding segment. Figure 2: Regional Performance Indorama Ventures 2nd Quarter 2018 MD&A 5
strong underlying performance as explained earlier. Figure 1: Core EBITDA Evolution V Note: Total of all regions may not match to IVL due to holding segment. Indorama Ventures 3rd Quarter 2018 MD&A 7
(as amend). Such issuance of the newly issued shares is treated as an offering which the Shareholders’ Meeting has a resolution clearly specified the offering price at THB 0.80 per share which is
recognized to match the actual revenue. In addition,the company has terminated its contractual partnership with the National Health Security Office .Meanwhile the revenue from general patient increased. 2